ArticleCureus2025
Triple Valve Endocarditis and Multiorgan Failure: A Clinical Conundrum.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Triple valve infective endocarditis is a rare clinical diagnosis with limited evidence on treatment strategies. Complications, including congestive heart failure, renal failure, and persistent bacteremia, predispose to increased mortality risk and limit surgical options. Due to its rarity, little is known about its prognosis and best treatment strategies. We present a case of a young man with multiple comorbidities, including liver cirrhosis and paroxysmal atrial fibrillation, who was diagnosed with right-sided infective endocarditis. Due to the patient's complex clinical course, his admission was complicated with infective endocarditis of the tricuspid valve, mitral valve, and aortic valve. Alongside its rarity, this case highlights the limited interventions at our disposal in treating triple valve endocarditis with multiple high-risk factors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.